Increased peroxisome proliferator-activated receptor γ activity reduces imatinib uptake and efficacy in chronic myeloid leukemia mononuclear cells

Lignende værker

• BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia
  af: Pagani, Ilaria S., et al.
  Udgivet: (2018)
• Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib
  af: Kok, Chung H., et al.
  Udgivet: (2019)
• Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-γ and synergizes with imatinib to inhibit chronic myeloid leukemia cells
  af: Kumar, Harish, et al.
  Udgivet: (2020)
• ABCC6 plays a significant role in the transport of nilotinib and dasatinib, and contributes to TKI resistance in vitro, in both cell lines and primary patient mononuclear cells
  af: Eadie, Laura N., et al.
  Udgivet: (2018)
• Contrasting effects of diclofenac and ibuprofen on active imatinib uptake into leukaemic cells
  af: Wang, J, et al.
  Udgivet: (2012)